Company
Bolt Biotherapeutics
Bolt Biotherapeutics has 3 drugs tracked on RxWires: 1 in Phase 2, 1 in Phase 1/2, 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| BDC-1001 | Phase 2 | Metastatic Breast Cancer |
| BDC-4182 | Phase 1/2 | Gastric Cancer Adenocarcinoma Metastatic |
| BDC-3042 | Phase 1 | Triple Negative Breast Cancer |
Latest
- bolt biotherapeutics filed 8-K
- bolt biotherapeutics filed 8-K
- bolt biotherapeutics filed 8-K
- bolt biotherapeutics filed 8-K
- bolt biotherapeutics filed 8-K
Follow Bolt Biotherapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.